TEVA
Teva Pharmaceutical Industries Ltd.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$41.31
−0.46%Forward multiples
Based on analyst estimates
- P/E forward
- 14.29x
- P/E 2026E
- 20.73x
- P/E 2027E
- 13.65x
- P/E 2028E
- 12.20x
- P/S forward
- 2.88x
Trailing multiples
Trailing twelve months
- P/E TTM
- 65.57x
- PEG TTM
- 0.18x
- Price / book
- 6.21x
- Price / sales
- 2.78x
- Price / cash flow
- 25.38x
Enterprise value
- Enterprise value
- $61.4B
- EV / sales
- 3.55x
- EV / EBITDA
- 23.67x
- EV / EBIT
- 30.96x
- Market cap
- $48.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026